Skip to main content
Fig. 3 | Acta Neuropathologica Communications

Fig. 3

From: Oral nicotinamide provides robust, dose-dependent structural and metabolic neuroprotection of retinal ganglion cells in experimental glaucoma

Fig. 3

Retinal ganglion cell dendrite changes following prophylactic low dose NAM (LNAM) treatment compared to untreated unilateral (N.H) glaucoma. The IOP profiles and Sholl analysis follow the conventions for Fig. 2. H. Typical labelled cells with wireframe reconstructions. Scale: 70 μm. ns = p > 0.05, * = p < 0.05, ** = p < 0.01, *** = p < 0.001, **** = p < 0.0001

Back to article page

Acta Neuropathologica Communications

ISSN: 2051-5960

Contact us